Advances in treatment decision-making for extrahepatic recurrence of intrahepatic cholangiocarcinoma

Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 12

Abstract

There has been a constant increase in the incidence rate of intrahepatic cholangiocarcinoma in China, and as a highly fatal malignancy, it often has an extremely poor prognosis. Surgical resection is the only possible way to cure this disease, but postoperative recurrence rate reaches as high as 50%‍ ‍—‍ ‍70%. While recurrence is commonly observed in the liver, 15%‍ ‍—‍ ‍30% of patients may experience extrahepatic recurrence. There are relatively few studies in the treatment strategies for extrahepatic recurrence, and there are still no clear guidelines for recommendation. Chemotherapy is currently the main treatment method for this disease. Studies have shown that some patients man achieve a prolonged survival time through surgical resection of extrahepatic recurrence sites, and in particular, such surgery is more feasible in patients with single focal lesion during recurrence. Nevertheless, surgery is only suitable to a small number of patients, and most patients still need to rely on systemic therapy and local treatment. Through a comprehensive analysis of related articles, this article summarizes the key influencing factors for extrahepatic recurrence, discusses the indications for surgery, and emphasizes the importance of individualized treatment strategies, in order to provide a reference for future treatment modalities.

Authors and Affiliations

Yihang WANG, Jiangtao LI

Keywords

Related Articles

Risk factors for biliary stricture and prognosis after orthotopic liver transplantation

[Objective] To investigate the risk factors for biliary stricture within two years after orthotopic liver transplantation, and analyze the survival. [Methods] A retrospective analysis was performed for the data of 495 p...

Research advances in the mechanism of action of nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome in autoimmune hepatitis

Autoimmune hepatitis (AIH) is chronic hepatitis caused by the attack of live cells by the immune system, and at present, the pathogenesis of AIH remains unclear. Inflammasomes are important components of innate immun...

Risk factors for death within 30 days after admission in patients with decompensated liver cirrhosis and acute kidney injury and construction of a nomogram model

[Objective] To investigate the predictive factors for death within 30 days after admission in patients with decompensated liver cirrhosis and acute kidney injury (AKI), and to establish and validate a nomogram predict...

Clinical effect of Foley catheter through sinus tract in treatment of complex pancreatic fistula with massive venous hemorrhage after pancreaticoduodenectomy: A case report

At present, vascular intervention and surgery are the main methods for the treatment of pancreatic fistula with bleeding after pancreaticoduodenectomy, but these treatment methods have certain drawbacks, such as the c...

Efficacy of transjugular intrahepatic portosystemic shunt in treatment of hepatocellular carcinoma comorbid with esophagogastric variceal bleeding

[Objective] To investigate the efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in preventing rebleeding in patients with hepatocellular carcinoma (HCC) comorbid with esophagogastric variceal bleeding...

Download PDF file
  • EP ID EP753958
  • DOI 10.12449/JCH241204
  • Views 10
  • Downloads 0

How To Cite

Yihang WANG, Jiangtao LI (2024). Advances in treatment decision-making for extrahepatic recurrence of intrahepatic cholangiocarcinoma. Journal of Clinical Hepatology, 40(12), -. https://europub.co.uk/articles/-A-753958